Vialwirebiotech, curated
July 3, 2026, 10:11 PM
May 14, 2026
- 2:50 PM · Endpoints News2:50 PM#ASGCT26: Encoded's gene therapy reduced seizures in Dravet syndrome — Endpoints News
- 12:09 PM · Drug Discovery World12:09 PMInfinitopes appoints CSO to advance immuno-oncology pipeline — Drug Discovery World
- 12:00 PM · Endpoints News12:00 PMDrugmakers have to go through rigorous tests to get a lower tariff rate — Endpoints News
- 10:31 AM · Endpoints News10:31 AMAstraZeneca follows Merck with Phase 3 win in bladder cancer — Endpoints News
- 10:10 AM · Endpoints News10:10 AMMacroGenics sells manufacturing arm; West Pharma discloses cybersecurity attack — Endpoints News
- 9:54 AM · Drug Discovery World9:54 AMGene editing technology could treat Hepatitis B — Drug Discovery World
- 9:23 AM · Pharmaceutical Executive9:23 AM<![CDATA[FDA Approves Beqalzi for Relapsed or Refractory Mantle Cell Lymphoma, Inqovi in Combination with Venetoclax]]> — Pharmaceutical Executive
- 7:32 AM · Endpoints News7:32 AMBiogen's anti-tau Alzheimer's drug misses Phase 2 goal, but claims signs of efficacy — Endpoints News
- 7:00 AM · Endpoints News7:00 AMRegenxbio hits Duchenne gene therapy milestone, eyes 2027 FDA approval — Endpoints News
- 6:31 AM · Endpoints News6:31 AMBeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta — Endpoints News
- 6:24 AM · Drug Discovery World6:24 AMMHRA to open Northern Ireland hub to boost life sciences — Drug Discovery World
- 5:00 AM · Drug Discovery World5:00 AMUK centre opens to accelerate Parkinson’s treatment research — Drug Discovery World
May 13, 2026
- 1:46 PM · Endpoints News1:46 PMValneva to cut up to 15% of jobs as reduced travel hits vaccine demand — Endpoints News
- 11:23 AM · BioPharma Dive11:23 AMLilly data point to ‘maintenance’ strategies for GLP-1 weight loss — BioPharma Dive
- 10:27 AM · BioPharma Dive10:27 AMAssertio accepts new buyout bid; AI biotech Isomorphic banks $2B — BioPharma Dive
- 9:28 AM · NYT — Science9:28 AMMarty Makary, Trump’s F.D.A. Commissioner, Resigns After Weeks of Pressure — NYT — Science
- 9:21 AM · Pharmaceutical Executive9:21 AM<![CDATA[Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu]]> — Pharmaceutical Executive
- 2:30 AM · Science (News)2:30 AMBoy’s brain tumor tied to gene therapy — Science (News)